Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fraser

Showing results (461-470 of 598) with videos related to

Pageof 60
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2013
Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypesMariana Chavez-Macgregor, Shuying Liu, Debora De Melo-Gagliato, et al.
The New England Journal of Medicine|December 1, 1977
Legionnaires' disease: description of an epidemic of pneumoniaD W Fraser, T R Tsai, W Orenstein, et al.
Trials|September 22, 2017
A cluster-randomized trial to reduce major perinatal morbidity among women with one prior cesarean delivery in Québec (PRISMA trial): study protocol for a randomized controlled trialN Chaillet, E Bujold, B Masse, et al.
The Oncologist|March 16, 2010
Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancersJacqueline Lehmann-Che, Fabrice André, Christine Desmedt, et al.
American Journal of Surgery|September 11, 2007
Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomyThao Vo, Yan Xing, Funda Meric-Bernstam, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 19, 2012
Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejectionF Porcheray, J DeVito, Y Helou, et al.
The Lancet. Oncology|March 2, 2010
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trialsNicolai Juul, Zoltan Szallasi, Aron C Eklund, et al.
Journal of the American Society of Cytopathology|December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomesGloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Management of Postprocedural Conduction Disturbances Using a Prespecified Algorithm in the Optimize PRO StudyKendra J Grubb, Steven J Yakubov, Tamim M Nazif, et al.
Cancer|July 25, 2006
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapyFlorentia Peintinger, W Fraser Symmans, Ana M Gonzalez-Angulo, et al.
Pageof 60

Showing results (461-470 of 598) with videos related to

Sort By:
Pageof 60
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2013
Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypesMariana Chavez-Macgregor, Shuying Liu, Debora De Melo-Gagliato, et al.
The New England Journal of Medicine|December 1, 1977
Legionnaires' disease: description of an epidemic of pneumoniaD W Fraser, T R Tsai, W Orenstein, et al.
Trials|September 22, 2017
A cluster-randomized trial to reduce major perinatal morbidity among women with one prior cesarean delivery in Québec (PRISMA trial): study protocol for a randomized controlled trialN Chaillet, E Bujold, B Masse, et al.
The Oncologist|March 16, 2010
Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancersJacqueline Lehmann-Che, Fabrice André, Christine Desmedt, et al.
American Journal of Surgery|September 11, 2007
Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomyThao Vo, Yan Xing, Funda Meric-Bernstam, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 19, 2012
Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejectionF Porcheray, J DeVito, Y Helou, et al.
The Lancet. Oncology|March 2, 2010
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trialsNicolai Juul, Zoltan Szallasi, Aron C Eklund, et al.
Journal of the American Society of Cytopathology|December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomesGloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Management of Postprocedural Conduction Disturbances Using a Prespecified Algorithm in the Optimize PRO StudyKendra J Grubb, Steven J Yakubov, Tamim M Nazif, et al.
Cancer|July 25, 2006
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapyFlorentia Peintinger, W Fraser Symmans, Ana M Gonzalez-Angulo, et al.
Pageof 60